Tremendous growth in the development of nanomaterials with enhanced performance characteristics which are being used for commercial and medical applications prompts researchers to take a proactive role in examining the nano-bio interface to identify potential risks of engineered nanomaterials and explore methods for safer designs for use in drug delivery therapeutics and commercial products.